Welcome to our dedicated page for Transact Tech SEC filings (Ticker: TACT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The TransAct Technologies Inc. (NASDAQ: TACT) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. TransAct files annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K covering financial results, material agreements and other significant corporate events.
Recent 8-K filings describe preliminary quarterly financial results, including net sales, gross profit, operating income or loss, net income or loss, EBITDA and adjusted EBITDA, as well as FST recurring revenue and casino and gaming net sales. These filings often attach press releases as exhibits and explain the company’s use of non-GAAP measures such as EBITDA and adjusted EBITDA, including why management and lenders consider them useful in evaluating operating performance.
Other 8-Ks detail material definitive agreements, such as the Source Code Purchase and Perpetual License Agreement with Avery Dennison for BOHA™ source code and a Third Amendment to the company’s headquarters lease in Hamden, Connecticut. These documents outline key terms, payment milestones, license rights and lease modifications that can affect TransAct’s operations and cost structure.
Through Stock Titan, users can follow TransAct’s real-time filing activity as new documents are posted to EDGAR, and then use AI-powered tools to summarize and interpret lengthy reports. This includes quickly understanding the main points in 10-K and 10-Q filings, reviewing 8-K disclosures about earnings releases and agreements, and examining exhibits related to technology licensing or facilities. The filings page is a resource for investors who want to analyze TransAct’s financial reporting, risk disclosures and contractual commitments directly from its official SEC submissions.
TRANSACT Technologies President and CFO Steven A. DeMartino reported equity award activity involving restricted stock units and common stock. On March 4, 2026, he exercised 12,500 restricted stock units, which converted into 12,500 shares of common stock at a stated price of
The restricted stock units were originally issued on September 4, 2024 under the company’s 2014 Equity Incentive Plan, vesting in eight equal quarterly installments over two years. After the conversion, DeMartino held 25,000 restricted stock units and 192,089 shares of common stock directly.
To cover tax obligations related to the award, 4,240 shares of common stock were disposed of in a tax-withholding transaction coded “F” at
TransAct Technologies Incorporated amended and restated its corporate by-laws, with the changes becoming effective on February 25, 2026, following approval by the Board of Directors. The company has filed the full text of the amended and restated by-laws as Exhibit 3.1, marked to show changes from the prior version.
TransAct Technologies Inc. insiders reported indirect acquisitions of common stock through restricted stock unit (RSU) conversions. On
The transactions include RSUs issued on
The filing is made jointly by 325 Capital LLC, 325 Capital Master Fund LP, 325 Capital GP, LLC, and individuals including director Daniel M. Friedberg and Anil K. Shrivastava, who may be deemed to share pecuniary interests and beneficial ownership but each disclaims beneficial ownership except to the extent of any pecuniary interest.
TransAct Technologies director Haydee Olinger reported multiple equity award conversions into common stock. On February 27, 28 and March 1–2, 2026, Restricted Stock Units granted under the company’s 2014 Equity Incentive Plan converted to common stock on a one-for-one basis at a price of $0.00 per share.
The transactions reflect derivative exercises or conversions, increasing directly held common stock through vesting of prior RSU grants from 2022, 2023, 2024 and 2025, each vesting 25% annually starting on the first anniversary of grant.
TransAct Technologies director Emanuel N. Hilario reported acquiring a total of 7,375 shares of common stock through exercises of restricted stock units between
After these derivative exercises and conversions, Hilario directly owns 29,100 shares of TransAct Technologies common stock. These transactions reflect the vesting and settlement of equity awards rather than open‑market purchases or sales.
TransAct Technologies Inc. director Randall S. Friedman reported multiple stock award vestings that converted into common shares. On February 27, 28, March 1 and March 2, 2026, he exercised Restricted Stock Units into matching amounts of common stock at a price of
The RSUs were originally granted between
TransAct Technologies director Audrey Dunning increased her direct common stock holdings through equity awards converting into shares. On February 27, February 28, and March 1, 2026, she exercised restricted stock units granted under the company’s 2014 Equity Incentive Plan, Amended and Restated, into common stock on a one-for-one basis at a reported price of $0.00 per share. Following these conversions, her directly owned common stock position is reported at 17,600 shares.
TransAct Technologies’ Chief Technology Officer Brent Richtsmeier reported a series of equity award conversions into common stock. On February 28 and March 1–2, he exercised vested restricted stock units and performance stock units, each converting to common stock on a one-for-one basis at a price of $0.00 per share. These were non‑cash transactions reflecting the vesting of awards under the company’s 2014 Equity Incentive Plan. Following the latest reported conversion on March 2, his direct ownership in common stock increased to 29,998 shares.
TransAct Technologies CEO John Dillon exercised previously granted Restricted Stock Units that vested under the company’s 2014 Equity Incentive Plan, converting 8,675 RSUs into the same number of common shares at a price of $0.00 per share.
After these derivative exercises and conversions on February 28, March 1, and March 2, Dillon directly owned 167,218 shares of common stock.
TransAct Technologies President and CFO Steven A. DeMartino reported multiple equity-award vesting events and related tax withholdings in late February and early March. On March 1, 2026, Performance Stock Units granted on March 1, 2023 converted into 7,629 shares of common stock, with some shares withheld to cover taxes. Restricted Stock Units granted in 2022, 2023 and 2024 also vested and converted one-for-one into common shares on February 28, March 1, and March 2, 2026. Several Form 4 entries coded “F” show shares delivered back to the company at prices around $3.46–$3.50 solely to satisfy tax or exercise obligations, rather than open-market sales, leaving DeMartino with a remaining direct holding of common stock.